These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 26419843)

  • 1. Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma.
    Tarhini AA; Zahoor H; Yearley JH; Gibson C; Rahman Z; Dubner R; Rao UN; Sander C; Kirkwood JM
    J Transl Med; 2015 Sep; 13():319. PubMed ID: 26419843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival.
    Alessi C; Scapulatempo Neto C; Viana CR; Vazquez VL
    Melanoma Res; 2017 Dec; 27(6):565-572. PubMed ID: 28984690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
    Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
    Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.
    Madore J; Vilain RE; Menzies AM; Kakavand H; Wilmott JS; Hyman J; Yearley JH; Kefford RF; Thompson JF; Long GV; Hersey P; Scolyer RA
    Pigment Cell Melanoma Res; 2015 May; 28(3):245-53. PubMed ID: 25477049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular primary cutaneous melanoma is associated with PD-L1 expression.
    Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Rodig S; Mihm M; Festa Neto C; Duncan LM; Kalil J
    Eur J Dermatol; 2020 Aug; 30(4):352-357. PubMed ID: 32969795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
    Goto Y; Ferrone S; Arigami T; Kitago M; Tanemura A; Sunami E; Nguyen SL; Turner RR; Morton DL; Hoon DS
    Clin Cancer Res; 2008 Jun; 14(11):3401-7. PubMed ID: 18519770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?
    Mukherji D; Jabbour MN; Saroufim M; Temraz S; Nasr R; Charafeddine M; Assi R; Shamseddine A; Tawil AN
    Clin Genitourin Cancer; 2016 Apr; 14(2):183-7. PubMed ID: 26775720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of Expression of PD-1 and PD-L1 In Head And Neck Squamous Cell Carcinoma And their Association With Nodal Metastasis: A Cross-Sectional Study.
    Malik IS; Asif M; Bashir N; Ara N; Rashid F; Din HU; Malik NS; Bashir A
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):467-473. PubMed ID: 35225458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.
    Kluger HM; Zito CR; Barr ML; Baine MK; Chiang VL; Sznol M; Rimm DL; Chen L; Jilaveanu LB
    Clin Cancer Res; 2015 Jul; 21(13):3052-60. PubMed ID: 25788491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
    Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes.
    Satzger I; Völker B; Meier A; Kapp A; Gutzmer R
    Ann Surg Oncol; 2008 Jun; 15(6):1723-32. PubMed ID: 18389323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Mass Spectrometry Analysis of PD-L1 Protein Expression,
    Morales-Betanzos CA; Lee H; Gonzalez Ericsson PI; Balko JM; Johnson DB; Zimmerman LJ; Liebler DC
    Mol Cell Proteomics; 2017 Oct; 16(10):1705-1717. PubMed ID: 28546465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.
    Harter PN; Bernatz S; Scholz A; Zeiner PS; Zinke J; Kiyose M; Blasel S; Beschorner R; Senft C; Bender B; Ronellenfitsch MW; Wikman H; Glatzel M; Meinhardt M; Juratli TA; Steinbach JP; Plate KH; Wischhusen J; Weide B; Mittelbronn M
    Oncotarget; 2015 Dec; 6(38):40836-49. PubMed ID: 26517811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAC1 P29S regulates PD-L1 expression in melanoma.
    Vu HL; Rosenbaum S; Purwin TJ; Davies MA; Aplin AE
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):590-8. PubMed ID: 26176707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
    Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH
    Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.